Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $32,848 | 1,539 | 98.8% |
| Education | $151.34 | 12 | 0.5% |
| Consulting Fee | $150.00 | 1 | 0.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $107.99 | 5 | 0.3% |
| Travel and Lodging | $4.58 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $2,733 | 121 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $2,430 | 68 | $0 (2024) |
| UCB, Inc. | $2,336 | 106 | $0 (2024) |
| ABBVIE INC. | $1,879 | 126 | $0 (2024) |
| SK Life Science, Inc. | $1,680 | 82 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,481 | 98 | $0 (2022) |
| Amgen Inc. | $1,462 | 47 | $0 (2024) |
| GENZYME CORPORATION | $1,345 | 44 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,327 | 76 | $0 (2024) |
| Lilly USA, LLC | $1,155 | 54 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,441 | 224 | ABBVIE INC. ($491.49) |
| 2023 | $3,838 | 211 | SK Life Science, Inc. ($465.51) |
| 2022 | $3,934 | 213 | ABBVIE INC. ($423.07) |
| 2021 | $3,751 | 182 | AbbVie Inc. ($505.69) |
| 2020 | $3,027 | 146 | Teva Pharmaceuticals USA, Inc. ($315.42) |
| 2019 | $4,706 | 198 | Teva Pharmaceuticals USA, Inc. ($454.30) |
| 2018 | $4,699 | 197 | Biogen, Inc. ($567.68) |
| 2017 | $4,866 | 187 | Teva Pharmaceuticals USA, Inc. ($623.86) |
All Payment Transactions
1,558 individual payment records from CMS Open Payments — Page 1 of 63
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Aucta Pharmaceuticals, Inc. | Motpoly XR (Drug) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: Central Nervous System | ||||||
| 12/18/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $22.49 | General |
| 12/17/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $25.04 | General |
| Category: Neurology | ||||||
| 12/16/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Neurology | ||||||
| 12/12/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: PAIN | ||||||
| 12/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Neuroscience | ||||||
| 12/10/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Neurology | ||||||
| 12/09/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Neurology | ||||||
| 12/09/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $2.03 | General |
| Category: Neurology | ||||||
| 12/05/2024 | Aucta Pharmaceuticals, Inc. | Motpoly XR (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Central Nervous System | ||||||
| 12/05/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Central Nervous System | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $32.52 | General |
| Category: Neurology | ||||||
| 12/03/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $29.89 | General |
| Category: PAIN | ||||||
| 12/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.77 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Neurology | ||||||
| 11/25/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/21/2024 | Biogen, Inc. | SKYCLARYS (Drug) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: Neurology | ||||||
| 11/18/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $7.19 | General |
| Category: PAIN | ||||||
| 11/14/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $17.69 | General |
| 11/11/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: PAIN | ||||||
| 11/07/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: NEUROLOGY | ||||||
| 11/06/2024 | Aucta Pharmaceuticals, Inc. | Motpoly XR (Drug) | Food and Beverage | In-kind items and services | $26.87 | General |
| Category: Central Nervous System | ||||||
| 11/05/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,496 | 2,075 | $801,542 | $299,054 |
| 2022 | 14 | 1,292 | 1,793 | $640,616 | $241,260 |
| 2021 | 13 | 1,252 | 1,764 | $592,193 | $231,700 |
| 2020 | 14 | 1,359 | 1,843 | $622,510 | $213,106 |
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 299 | 563 | $175,093 | $75,920 | 43.4% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 170 | 173 | $126,982 | $61,675 | 48.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 308 | 470 | $109,040 | $44,462 | 40.8% |
| 95957 | Measurement of brain wave activity (eeg), digital analysis | Office | 2023 | 189 | 193 | $147,452 | $42,224 | 28.6% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 113 | 228 | $98,708 | $23,450 | 23.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 81 | 81 | $36,126 | $13,708 | 37.9% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 109 | 111 | $31,074 | $10,920 | 35.1% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2023 | 110 | 112 | $22,236 | $7,803 | 35.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 21 | 21 | $13,818 | $6,234 | 45.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 38 | 65 | $16,250 | $4,995 | 30.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $7,160 | $2,410 | 33.7% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 14 | 14 | $7,784 | $2,393 | 30.7% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 13 | 13 | $5,980 | $1,841 | 30.8% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 11 | 11 | $3,839 | $1,019 | 26.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 407 | 716 | $166,112 | $65,874 | 39.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 248 | 389 | $120,979 | $52,036 | 43.0% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2022 | 109 | 110 | $80,740 | $38,791 | 48.0% |
| 95957 | Measurement of brain wave activity (eeg), digital analysis | Office | 2022 | 134 | 135 | $103,140 | $28,665 | 27.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 74 | 74 | $33,004 | $12,384 | 37.5% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 27 | 27 | $17,766 | $8,476 | 47.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 66 | 66 | $23,628 | $8,243 | 34.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 55 | 95 | $23,750 | $7,781 | 32.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 47 | 47 | $20,633 | $7,163 | 34.7% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 32 | 32 | $14,720 | $4,273 | 29.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 20 | 26 | $5,876 | $2,137 | 36.4% |
About Dr. Jiangping Liu, MD
Dr. Jiangping Liu, MD is a Neurology healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518971027.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jiangping Liu, MD has received a total of $33,262 in payments from pharmaceutical and medical device companies, with $4,441 received in 2024. These payments were reported across 1,558 transactions from 81 companies. The most common payment nature is "Food and Beverage" ($32,848).
As a Medicare-enrolled provider, Liu has provided services to 5,399 Medicare beneficiaries, totaling 7,475 services with total Medicare billing of $985,120. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Fort Worth, TX
- Active Since 07/28/2006
- Last Updated 09/30/2011
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1518971027
Products in Payments
- APTIOM (Drug) $1,780
- Briviact (Drug) $1,736
- Aimovig (Biological) $1,379
- UBRELVY (Drug) $1,047
- AUBAGIO (Drug) $995.46
- QULIPTA (Drug) $937.82
- OXTELLAR XR (Drug) $918.68
- TYSABRI (Biological) $903.02
- NURTEC ODT (Drug) $891.09
- TECFIDERA (Drug) $740.99
- NUEDEXTA (Drug) $688.63
- KESIMPTA (Drug) $670.14
- Fycompa (Drug) $625.32
- COPAXONE (Drug) $576.61
- EMGALITY (Drug) $561.72
- SOLIRIS (Drug) $531.24
- AJOVY (Drug) $530.76
- AJOVY (Biological) $530.01
- XCOPRI (Drug) $520.36
- UPLIZNA (Drug) $496.91
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Fort Worth
Dr. Hamid Kadiwala, M.d, M.D
Neurology — Payments: $139,323
Horacio Chiong-Rivero, M.d., Ph.d, M.D., PH.D
Neurology — Payments: $83,086
Sharique Ansari, M.d., Mph, M.D., MPH
Neurology — Payments: $79,831
Krishnababu Chunduri, Md, MD
Neurology — Payments: $41,859
Leila Bostan Shirin, M.d, M.D
Neurology — Payments: $35,690
Dr. Mary Quiceno, M.d, M.D
Neurology — Payments: $28,815